ShiraTronics, a clinical-stage innovator in neuromodulation technology, today announced the initiation of its U.S. Food and Drug Administration (FDA)-approved Investigation Device Exemption (IDE) ...
Botox (botulinum toxin type A) is also used by the NHS for the treatment of chronic migraine in adults, defined as having at least 15 headache days a month. Helen Knight, director of medicines ...
“There was some evidence that early treatment with Paxlovid can reduce the risk of long-term COVID.” Indeed, people in high-risk groups can lower the chance of dealing with additional symptoms, called ...